ES2059482T3 - Expresion de la proteasa p2a de hrv2 codificada por virus. - Google Patents

Expresion de la proteasa p2a de hrv2 codificada por virus.

Info

Publication number
ES2059482T3
ES2059482T3 ES88121480T ES88121480T ES2059482T3 ES 2059482 T3 ES2059482 T3 ES 2059482T3 ES 88121480 T ES88121480 T ES 88121480T ES 88121480 T ES88121480 T ES 88121480T ES 2059482 T3 ES2059482 T3 ES 2059482T3
Authority
ES
Spain
Prior art keywords
expression
hrv2
protease
viruses
coded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121480T
Other languages
English (en)
Inventor
Wolfgang Dr Sommergruber
Friederike Fessl
Ernst Prof Dr Kuchler
Dieter Dipl-Ing Dr Blaas
Timothy Dr Skern
Manfred Zorn
Markus Duchler
Heinrich Kowalski
Peter Dr Volkmann
Ingrid Dr Maurer-Fogy
Peter Dr Pallai
Vincent Dr Merluzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873743848 external-priority patent/DE3743848A1/de
Priority claimed from DE19883825118 external-priority patent/DE3825118A1/de
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2059482T3 publication Critical patent/ES2059482T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Abstract

OBJETO DE LA PRESENTE INVENCION SON MOLECULAS DE DNA QUE CODIFICAN PARA PROTEINAS DE FUSION PARTIENDO DE PARTES ACTIVAS ENZIMATICAMENTE Y PARTES DE POLIPEPTIDOS SEPARABLES DE ESTAS, SISTEMAS DE EXPRESION QUE CONTIENEN ESAS MOLECULAS DE DNA, ASI COMO LA UTILIZACION DE ESTOS COMO SISTEMAS DE TEST PARA INHIBIDORES DE PROTEASAS VIRALES.
ES88121480T 1987-12-23 1988-12-22 Expresion de la proteasa p2a de hrv2 codificada por virus. Expired - Lifetime ES2059482T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873743848 DE3743848A1 (de) 1987-12-23 1987-12-23 Expression der viral kodierten protease p2a des hrv2
DE19883825118 DE3825118A1 (de) 1988-07-23 1988-07-23 Expression der viral kodierten protease p2a des hrv2

Publications (1)

Publication Number Publication Date
ES2059482T3 true ES2059482T3 (es) 1994-11-16

Family

ID=25863170

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121480T Expired - Lifetime ES2059482T3 (es) 1987-12-23 1988-12-22 Expresion de la proteasa p2a de hrv2 codificada por virus.

Country Status (5)

Country Link
US (1) US5149783A (es)
EP (1) EP0321973B1 (es)
JP (1) JPH0231678A (es)
DE (1) DE3885431D1 (es)
ES (1) ES2059482T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903144A0 (fi) * 1989-06-25 1990-06-21 Boehringer Ingelheim Int Modifierade vp1/p2a zoner i snuvvirussystemet.
EP0421109A3 (en) * 1989-09-11 1992-01-08 American Cyanamid Company Screening methods for protease inhibitors
AU638774B2 (en) * 1989-11-20 1993-07-08 Eli Lilly And Company Methods of treating retroviral infection
AU7742691A (en) * 1990-04-13 1991-11-11 Schering Corporation Novel protease assays
US5599906A (en) * 1990-04-13 1997-02-04 Schering Corporation Protease assays
JPH05506999A (ja) * 1990-08-28 1993-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスプロティナーゼの活性をモニターするためのテスト系
JP3142638B2 (ja) * 1991-06-21 2001-03-07 三井化学株式会社 感熱記録材料およびフェノール化合物
WO1993001305A1 (en) * 1991-07-09 1993-01-21 Robert Balint A method for the identification of protease inhibitors
DE4136443A1 (de) * 1991-11-06 1993-05-13 Boehringer Ingelheim Int Expression der reifen proteinase 2a, ihre partielle reinigung und bereitstellung kompetitiv wirkender substrate
MX9206981A (es) * 1991-12-06 1994-08-31 Whitehead Biomedical Inst Vacunas de recombinantes y metodo para producirlas.
US5955072A (en) 1994-07-13 1999-09-21 Sankyo Company, Limited Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
US6063562A (en) * 1994-09-16 2000-05-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst
US5912167A (en) * 1995-06-06 1999-06-15 Wisconsin Alumni Research Foundation Autocatalytic cleavage site and use thereof in a protein expression vector
US5763196A (en) * 1996-01-26 1998-06-09 Boehringer Mannheim Corporation Assays using cross-linked polypeptide fragments of β-galactosidase
DE69709448T2 (de) * 1996-01-26 2002-09-19 Roche Diagnostics Corp Bismaleinsäureimid-vernetzer
US5976857A (en) * 1996-01-26 1999-11-02 Boehringer Mannheim Corporation Cross-linked polypeptide fragments of β-galactosidase
TR200200253T2 (tr) 1999-08-09 2002-05-21 Bio-Chemie Gesellschaft M.B.H. Proteinlerin üretimi
TR200200048T2 (tr) 1999-08-09 2002-04-22 Biochemie Gesellschaft M.B.H. Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi.
US6861234B1 (en) 2000-04-28 2005-03-01 Mannkind Corporation Method of epitope discovery
US20030215425A1 (en) * 2001-12-07 2003-11-20 Simard John J. L. Epitope synchronization in antigen presenting cells
EP1910550A4 (en) 2005-07-21 2009-11-04 Abbott Lab MULTIGENIC EXPRESSION COMPRISING SORF CONSTRUCTS AND METHODS USING POLYPROTEINS, PRO-PROTEINS, AND PROTEOLYSIS
CN102812040A (zh) * 2009-10-30 2012-12-05 雅培制药有限公司 Sorf构建体和多基因表达

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652552A (en) * 1984-09-10 1987-03-24 E. I. Du Pont De Nemours And Company Tetrapeptide methyl ketone inhibitors of viral proteases
DE3505148A1 (de) * 1985-02-15 1986-10-30 Boehringer Ingelheim International GmbH, 6507 Ingelheim Polypeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele

Also Published As

Publication number Publication date
US5149783A (en) 1992-09-22
EP0321973B1 (de) 1993-11-03
JPH0231678A (ja) 1990-02-01
DE3885431D1 (de) 1993-12-09
EP0321973A2 (de) 1989-06-28
EP0321973A3 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
ES2059482T3 (es) Expresion de la proteasa p2a de hrv2 codificada por virus.
ATE33558T1 (de) Stabilisierung von influenzavirusimpfstoffen.
ES2075883T3 (es) Proteinas antigeno de nucleo de hepadnavirus quimericas.
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ES2195998T3 (es) Sistemas de expresion de dna basados en alfavirus.
DE69840966D1 (de) Homolog NL6 des Tie Rezeptor Tyrosinekinase Liganden
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ES2108850T3 (es) Nitrilasa recombinante y su utilizacion.
NO882380L (no) Fibfonektin-bindende protein, samt fremstilling derav.
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
DK1681299T3 (da) Fremgangsmåde til rensning af højt anioniske proteiner
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ES2090357T3 (es) Una proteina de union a colageno asi como su preparacion.
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
ES2125236T3 (es) Mejoras relativas a la deteccion de virus.
ES2128317T3 (es) Polipeptidos implicados en la biosintesis de las cobalaminas y/o cobamidas, secuencias de adn que codifican estos polipeptidos, procedimiento de preparacion y su utilizacion.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
ATE214731T1 (de) Neuartige protease
BR112022006578A2 (pt) Polipeptídeos de fusão e de hemaglutinina do vírus da cinomose canina
DE3825118A1 (de) Expression der viral kodierten protease p2a des hrv2
ES2091223T3 (es) Nuevas secuencias de adn que codifican polipeptidos semejantes a ancrod y composiciones que comprenden los productos de expresion de las mismas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 321973

Country of ref document: ES